News | ECMO Systems | February 22, 2018

New Protocol Gives Patients Fighting Chance to Survive Cardiac Arrest

ECMO-based protocol improves sudden cardiac arrest survival from 0 to 40 percent

New Protocol Gives Patients Fighting Chance to Survive Cardiac Arrest

February 22, 2018 — When someone goes into cardiac arrest and first responders cannot shock their heart back into rhythm, there is virtually no chance of survival. However, a new protocol being tested at The Ohio State University Wexner Medical Center is already saving lives – increasing survival rates from zero to about 40 percent.

“It’s astounding that patients are able to fully recover and walk out of the hospital when they would have been pronounced dead in the field before this protocol was in place,” said K. Dean Boudoulas, M.D., a cardiologist and assistant professor of internal medicine at The Ohio State University Wexner Medical Center.

The extracorporeal cardiopulmonary resuscitation (ECPR) protocol was developed through a partnership with the Columbus Division of Fire. It is initiated by EMS if they are not able to restore normal rhythm after shocking a patient’s heart three times. After alerting the hospital, emergency personnel connect the patient to a device that automatically delivers CPR to preserve the patient’s brain and organ function on the way to the hospital. Upon arrival, the patient bypasses the emergency room and is taken straight to the heart catheterization lab where they are connected to an extracorporeal membrane oxygenation (ECMO) machine.

“This allows the heart and lungs to rest while doctors perform a heart catheterization to find the problem, which is usually a blocked artery,” said Bryan Whitson, M.D., Ph.D., director of the Collaboration for Organ Perfusion, Protection, Engineering and Regeneration at Ohio State.

With positive results from this and other pilot studies, experts hope that the protocol will become standard care in treating cardiac arrests.

Watch the VIDEO: Ohio State University Introduces ECMO Protocol for Cardiac Arrest

For more information:


Related Content

Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
FFR software on the GE Centricity CVIS. A trial from the 2018 EuroPCR meeting showed FFR improves long-term outcomes.
News | Cath Lab | May 29, 2018
May 29, 2018 — Ongoing controversy exists regarding the role of percutaneous coronary intervention (PCI) for stable c
SCAI Updates Consensus on Length of Stay for Percutaneous Coronary Intervention
News | Cath Lab | May 15, 2018
Revised guidelines incorporating new data on discharge criteria for patients undergoing elective percutaneous coronary...
No Benefit Found Using Sodium Bicarbonate, Acetylcysteine to Prevent Kidney Injury, the result of the PRESERVE Trial to prevent acute kidney injury (AKI), presented at SCAI 2018.  #SCAI, #SCAI2018,
Feature | Cath Lab | May 15, 2018
May 15, 2018 – The large-scale, international randomized PRESERVE clinical trial found high-risk patients for renal c
Angiogram of a STEMI patient.
News | Cath Lab | May 15, 2018
May 15, 2018 — A contemporary, real-world analysis shows lower mortality rates when culprit-only intervention is used
Recent Acquisitions Eroding Prices in Billion Dollar European Interventional Cardiology cath lab Market.
Feature | Cath Lab | May 07, 2018 | Simon Trinh and Jeffrey Wong
The European interventional cardiology market is currently valued at nearly $1.4 billion.
Videos | Cath Lab | May 07, 2018
Imran Ahmad, M.D., medical director of interventional cardiology, explains some of the new technologies his labs have
360 Photos | Cath Lab | April 20, 2018
A 360 degree view of the newest cath lab at Northwestern Medicine Central DuPage Hospital in Winfield, Ill., located
SCAI Announces Global Lecture Series for 2018 Scientific Sessions
News | Cath Lab | April 18, 2018
Many of the world’s leading interventional cardiologists and cardiovascular professionals will convene in San Diego,...
Serial coronary angiograms of the representative case treated with shockwave intravascular lithotripsy.

Figure 1. Serial coronary angiograms of the representative case treated with shockwave intravascular lithotripsy.

Feature | Cath Lab | April 16, 2018 | Azeem Latib, M.D.
Over the last decade, there have been considerable developments in procedural techniques and technology facilitating
Overlay Init